Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the adult treatment panel III guidelines

American Journal of Cardiology

Volumn 96, Issue 9, 2005, Pages 1260-1265

  Muntner, Paul ^a,b   Gu, Dongfeng ^c   Reynolds, Robert F ^d   Wu, Xigui ^c   Chen, Jichun ^c   Whelton, Paul K ^a,b   He, Jiang ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUWAI HOSPITAL   (China)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ASIA; CHINESE; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SERUM;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHINA; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PREVALENCE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 27144450134     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.068     Document Type: Article

References (13)

1. NCEP Expert Panel Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr, L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr, N.J. Stone Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
3. F. Qi, W. Zhonglin, N. Tianhai, S. Geng, C. Zaijia, L. Zongliang, L. Chuanxiong, Z. Beifan, Z. Junren, Z. Yongkang Suggestions of prevention and treatment of dyslipidemia Chin J of Cardiol 255 1997 169 175
4. J. He, B. Neal, D. Gu, P. Suriyawongpaisal, X. Xin, R. Reynolds, S. MacMahon, P.K. Whelton International collaborative study of cardiovascular disease in Asia design, rationale, and preliminary results Ethn Dis 14 2004 260 268
5. C.C. Allain, L.S. Poon, C.S. Chan, W. Richmond, P.C. Fu Enzymatic determination of total serum cholesterol Clin Chem 20 1974 470 475
6. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
7. D. Perloff, C.E. Grim, J.M. Flack, E.D. Frohlich, M. Hill, M. McDonald, B.Z. Morgenstern Human blood pressure determination by sphygmomanometry Circulation 88 1993 2460 2470
8. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
9. J. Liu, Y. Hong, R.B. D'Agostino Sr, Z. Wu, W. Wang, J. Sun, P.W. Wilson, W.B. Kannel, D. Zhao Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 291 2004 2591 2599
10. StataCorp STATA statistical software, release 6.0 1999 STATA Corporation College Station, TX
11. A.D. Lopez Assessing the burden of mortality from cardiovascular diseases World Health Stat Q 46 1993 91 96
12. C.J.L. Murray, A.D. Lopez The Global Burden of Disease A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 1996 Harvard School of Public Health Boston 1 990
13. M. Ezzati, S.V. Hoorn, A. Rodgers, A.D. Lopez, C.D. Mathers, C.J. Murray Estimates of global and regional potential health gains from reducing multiple major risk factors Lancet 362 2003 271 280